ESR1 and breast carcinoma: Comparable results were observed with ZR-75-1 human ER+ breast cancer cells, with release from dormancy enhanced with cancer-associated fibroblast (CAF) CM compared to normal fibroblast CM (Extended Data Fig. 2d).